hotspot -WSS

hotspot

author：focus 2025-09-28 02:30:37 - browse：1156

Photo illustration of the FDA US Food and Drug website. -- health policy coverage from STAT — Adobe

WASHINGTON — Food and Drug Administration officials hope to finish this year a massive overhaul of the way the agency inspects facilities that make drugs, medical devices, and food products, they said Friday.

The reorganization was spurred by the FDA’s mishandling of the infant formula crisis. The agency was slow to inspect a major infant formula plant despite a whistleblower complaint about deadly bacterial contamination at the facility. An investigation found that the delayed response was due in part to the agency’s organization. A nonprofit, nonpartisan advisory body reported in December it was not clear who is in charge of food oversight, and agency food safety staff are siloed among divisions that don’t communicate with each other.

Although the food center has been the focus of attention in the reorganization, it will affect a huge swath of the agency. The reorganization is expected to impact about 8,000 FDA employees, according to Michael Rogers, FDA associate commissioner for regulatory affairs. The Office of Regulatory Affairs, which will be called the Office of Inspections and Investigations under the proposed reorganization, will go from having about 5,100 full-time employees to 3,586 employees.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Stephen Quake on the Chan Zuckerberg quest to conquer disease

leisure time

WSS

Health care court cases: Humana, Sutter, Novant

The system is set up to fail children with medical complexity

CVS Caremark has created a new ploy: the drug ‘rebate credit’

U.K. researchers warn about biases in medical devices, algorithms

Cheap, fast test for Zika and dengue could cost just $1

Neuroscience’s long legacy of racism

entertainment

hotspot

explore

Trump demands the U.S. pay no more for drugs than other countries … again

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

New air purifier tech could be key to improving indoor air quality

Pharma companies must ensure equitable access to obesity drugs

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Leading voice in opioid treatment defends methadone clinic system

How one medical school became remarkably diverse

U.K. researchers warn about biases in medical devices, algorithms

ChatGPT in medicine: STAT answers readers' burning questions

Medical device trials still don't enroll enough women, study finds

hotspot

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Cigna wins case to block Amy Bricker's move to CVS

Curing rare childhood diseases will falter unless Congress steps up

How faith leaders like me can help address America's obesity epidemic

Orchard's therapy for neuron disease in children wins FDA approval

Medical device trials still don't enroll enough women, study finds

focus

hotspot

leisure time

explore